Atopic dermatitis. Besnier's prurigo
Conditions
Interventions
Intervention 1: Intervention group: 5 % tumeric extract in microemulgel. patients were instructed to apply the Herbal microemulgel twice a day. Intervention 2: Control group: microemulgel without tum
Treatment - Drugs
Placebo
Intervention group: 5 % tumeric extract in microemulgel. patients were instructed to apply the Herbal microemulgel twice a day
Control group: microemulgel without tumeric extract. patients were instructed to apply twice a day.
Sponsors
Islamic azad university of pharmaceutical sciense
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age over 18 years old; both sexes; absence of infection or skin cancer; patients with mild & moderate plaque eczema which had been stable on systemic treatment for at least 2 month; wash out period for topical anti eczema agent at least 2 weeks before clinical trial. Exclusion criteria: pregnancy; lactation; age under 18 years old; a history of sensitivity to the active ingredient or expedients; patient decision to leave the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema. Timepoint: at the baseline, every 3 weeks up to 12 weeks. Method of measurement: photography: before,during &after treatment and questionnair of life of quality and scorad.;Dryness. Timepoint: at the baseline, every 3 weeks up to 12 weeks. Method of measurement: photography: before,during &after treatment and questionnair of life of quality and scorad.;Burning. Timepoint: at the baseline, every 3 weeks up to 12 weeks. Method of measurement: questionnair.;Itching. Timepoint: at the baseline, every 3 weeks up to 12 weeks. Method of measurement: questionnair. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: at the baseline, every 3 weeks up to 12 weeks. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed